课题基金 / 基金详情

Expression and regulation of human genes central to drug disposition in the brain

Expression and regulation of human genes central to drug disposition in the brain
人类基因的表达和调节对于大脑中的药物分布至关重要
批准号:
nhmrc : 352320
负责人:
A/Pr Graham Robertson
金额:
$22.63万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2005
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2005-01-01 至 2007-12-31

项目摘要

项目成果

A/Pr Graham Robertson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The study of the regulation of human genes is inherently difficult. It is difficult or impossible to gain access to many body tissues in either healthy or sick individuals to examine coordinated gene function (or dysfunction). This is particularly true for the brain, where live human tissue is unavailable. For this reason, it is often the case that we have a much better understanding of gene function in species such as rats and mice, the most common animal environments for biomedical research. However, findings in animals often fail to meaningfully mirror what occurs in man. To progress our understanding of human genes in brain we need to develop models that more faithfully reproduce the human situation in an environment that is amenable to both manipulation and close examination, such as the novel 'humanized' mouse models described in this application. This application deals with the genes that control enzymes belonging to the human cytochrome P450 3A (CYP3A) subfamily and the drug transporter MDR1. These genes are present in several tissues including liver, gut, lung and brain. They form the main disposal pathway for foreign chemicals such as drugs, environmental pollutants and some cancer causing chemicals. In addition they are involved in the breakdown of several important internally produced substances, such as steroid hormones. We postulate that altered formation of CYP3A enzymes and MDR1 in brain can have a dramatic impact on the action of many important drugs and may affect the way the brain responds in a behavioral sense to hormones, such as sex steroids. In addition, this work will provide a new and useful information relevant to the design and development of the plethora of drugs that act on the central nervous system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nutrition and rehabilitation in advanced cancer patients
  • 批准号:
    nhmrc : 446208
  • 项目类别:
    Targeted Calls
  • 资助金额:
    $15.07万
  • 财政年份:
    2007
  • 负责人:
    A/Pr Graham Robertson
  • 依托单位:
Repression of hepatic drug metabolism by solid tumours
  • 批准号:
    nhmrc : 352419
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $33.61万
  • 财政年份:
    2005
  • 负责人:
    A/Pr Graham Robertson
  • 依托单位:
Alternate signalling pathways regulating the human arachidonate epoxygenase CYP2J2 in response to stress stimuli
  • 批准号:
    nhmrc : 301909
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $24.6万
  • 财政年份:
    2004
  • 负责人:
    A/Pr Graham Robertson
  • 依托单位:
Molecular mechanisms of feed-forward regulation of bile acid detoxification and elimination in cholestasis
  • 批准号:
    nhmrc : 302036
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $22.3万
  • 财政年份:
    2004
  • 负责人:
    A/Pr Graham Robertson
  • 依托单位:
国内基金
海外基金
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
  • 批准号:
    82371801
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    周海波
  • 依托单位:
精氨酸调控骨髓Tregs稳态在脓毒症骨髓功能障碍中的作用研究
  • 批准号:
    82371770
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    宁铂涛
  • 依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位:
亚低温调控颅脑创伤急性期神经干细胞Mpc2/Lactate/H3K9lac通路促进神经修复的研究
  • 批准号:
    82371379
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    冯军峰
  • 依托单位: